TNSN08222A1 - New compounds - Google Patents
New compoundsInfo
- Publication number
- TNSN08222A1 TNSN08222A1 TNP2008000222A TNSN08222A TNSN08222A1 TN SN08222 A1 TNSN08222 A1 TN SN08222A1 TN P2008000222 A TNP2008000222 A TN P2008000222A TN SN08222 A TNSN08222 A TN SN08222A TN SN08222 A1 TNSN08222 A1 TN SN08222A1
- Authority
- TN
- Tunisia
- Prior art keywords
- group
- optionally substituted
- heterocyclyl
- disorders
- arc
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 102000012777 Metabotropic Glutamate 5 Receptor Human genes 0.000 abstract 2
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- -1 trif1uOfomelhyl Chemical group 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 241001024304 Mino Species 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002232 neuromuscular Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0501171A HU0501171D0 (en) | 2005-12-20 | 2005-12-20 | New compounds |
| PCT/HU2006/000123 WO2007072095A1 (en) | 2005-12-20 | 2006-12-19 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN08222A1 true TNSN08222A1 (en) | 2009-10-30 |
Family
ID=89986471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2008000222A TNSN08222A1 (en) | 2005-12-20 | 2008-05-15 | New compounds |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN101341152A (zh) |
| HU (1) | HU0501171D0 (zh) |
| TN (1) | TNSN08222A1 (zh) |
| TW (1) | TW200838865A (zh) |
| ZA (1) | ZA200805293B (zh) |
-
2005
- 2005-12-20 HU HU0501171A patent/HU0501171D0/hu unknown
-
2006
- 2006-12-19 CN CNA2006800481842A patent/CN101341152A/zh active Pending
-
2007
- 2007-03-16 TW TW096109178A patent/TW200838865A/zh unknown
-
2008
- 2008-05-15 TN TNP2008000222A patent/TNSN08222A1/en unknown
- 2008-06-18 ZA ZA200805293A patent/ZA200805293B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU0501171D0 (en) | 2006-02-28 |
| CN101341152A (zh) | 2009-01-07 |
| TW200838865A (en) | 2008-10-01 |
| ZA200805293B (en) | 2009-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2545427A1 (en) | Selective kinase inhibitors | |
| MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
| WO2007022934A3 (en) | Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine d3 receptors | |
| AU5257401A (en) | Novel bicyclic compounds | |
| MY141229A (en) | Piperidine-benzenesulfonamide derivatives | |
| TW200732339A (en) | Nitrogen-containing bicyclic heteroaryl compounds and methods of use | |
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| IL157179A0 (en) | Fused heterocyclic compounds | |
| ATE479690T1 (de) | Thienoä2,3-büpyridin derivate | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| NZ515282A (en) | Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions | |
| UA95766C2 (ru) | Производные терфенила для лечения болезни альцгеймера | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| WO2007054444A3 (en) | 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives | |
| TW200734328A (en) | Aryl-isoxazolo-4-yl-imidazo [1,5-a] pyridine derivatives | |
| MX2007013606A (es) | (3,4-dihidro-quinazolin2-il)-(2-ariloxi-etil)-aminas que tienen una actividad en el receptor 5-ht. | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| BR112012032813A2 (pt) | composto, composição farmacêutica, e, método para prevenir, tratar ou melhorar uma doença ou condição. | |
| PL1819698T3 (pl) | Pochodne 1-[(6-podstawione alkoksychinoksalinylo)aminokarbonylo]-4-(hetero)arylopiperazyny | |
| TW200724143A (en) | Novel compounds for the treatment of inflammatory diseases | |
| MXPA05012368A (es) | Derivados de amidas del acido 2,3,4,5-tetrahidrobenzo[f] [1,4]oxazepina-5-carboxilico como inhibidores de gamma-secretasa para el tratamiento de la enfermedad de alzheimer. | |
| MXPA04004308A (es) | Derivados de piridina como ligandos del receptor n-metil-d-aspartato (nmda). | |
| MX2009010243A (es) | Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6. | |
| WO2007119004A3 (fr) | Methode de diagnostic in vitro ou ex vivo de desordres psychiatriques et/ou de dysbioses intestinales |